Ovid Therapeutics to Participate in Upcoming Investor Conferences
Ovid Therapeutics Inc., a biopharmaceutical company specializing in treatments for brain disorders with significant unmet needs, announced its management will participate in two upcoming investor conferences. The presentations will provide updates on their pipeline, including therapies targeting treatment-resistant seizures and neuropsychiatric dis…